AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
EPTIFIBATIDE PHARMACOKINETICS IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY
Authors: VANWART S KOSOGLOU T TCHENG JE LORENZ T ALTON K BELANGER B RADWANSKI E
Citation: S. Vanwart et al., EPTIFIBATIDE PHARMACOKINETICS IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 103-103
PHARMACOKINETICS AND DYNAMICS (CYTOKINE SUPPRESSION) OF IV AND SC RECOMBINANT HUMAN INTERLEUKIN-19
Authors: RADWANSKI E CHAKRABORTY A VANWART S CUTLER DL AFFRIME MB JUSKO WJ
Citation: E. Radwanski et al., PHARMACOKINETICS AND DYNAMICS (CYTOKINE SUPPRESSION) OF IV AND SC RECOMBINANT HUMAN INTERLEUKIN-19, Clinical pharmacology and therapeutics, 63(2), 1998, p.
IN-VIVO IN-VITRO CORRELATION OF 4 EXTENDED-RELEASE FORMULATIONS OF PSEUDOEPHEDRINE SULFATE/
Authors: MOJAVERIAN P ROSEN J VADINO WA LIEBOWITZ S RADWANSKI E
Citation: P. Mojaverian et al., IN-VIVO IN-VITRO CORRELATION OF 4 EXTENDED-RELEASE FORMULATIONS OF PSEUDOEPHEDRINE SULFATE/, Journal of pharmaceutical and biomedical analysis, 15(4), 1997, pp. 439-445
PHARMACOKINETICS OF LORATADINE AND PSEUDOEPHEDRINE FOLLOWING SINGLE AND MULTIPLE DOSES OF ONCE-DAILY VERSUS TWICE-DAILY COMBINATION TABLET FORMULATIONS IN HEALTHY ADULT MALES
Authors: KOSOGLOU T RADWANSKI E BATRA VK LIM JM CHRISTOPHER D AFFRIME MB
Citation: T. Kosoglou et al., PHARMACOKINETICS OF LORATADINE AND PSEUDOEPHEDRINE FOLLOWING SINGLE AND MULTIPLE DOSES OF ONCE-DAILY VERSUS TWICE-DAILY COMBINATION TABLET FORMULATIONS IN HEALTHY ADULT MALES, Clinical therapeutics, 19(5), 1997, pp. 1002-1012
SINGLE-DOSE PHARMACOKINETICS OF ISEPAMICIN IN YOUNG AND GERIATRIC VOLUNTEERS
Authors: NOMEIR AA RADWANSKI E CUTLER D AFFRIME M CHRISTOPHER D KORDUBA C BATRA V LIN CC CAYEN MN
Citation: Aa. Nomeir et al., SINGLE-DOSE PHARMACOKINETICS OF ISEPAMICIN IN YOUNG AND GERIATRIC VOLUNTEERS, Journal of clinical pharmacology, 37(11), 1997, pp. 1021-1030
PHARMACOKINETICS OF ISEPAMICIN FOLLOWING A SINGLE ADMINISTRATION BY INTRAVENOUS-INFUSION OR INTRAMUSCULAR INJECTIONS
Authors: RADWANSKI E BATRA V CAYEN M KORDUBA C CUTLER D AFFRIME M NOMEIR A LIN CC
Citation: E. Radwanski et al., PHARMACOKINETICS OF ISEPAMICIN FOLLOWING A SINGLE ADMINISTRATION BY INTRAVENOUS-INFUSION OR INTRAMUSCULAR INJECTIONS, Antimicrobial agents and chemotherapy, 41(8), 1997, pp. 1794-1796
PHARMACODYNAMICS OF SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-10 IN HEALTHY-VOLUNTEERS
Authors: HUHN RD RADWANSKI E GALLO J AFFRIME MB SABO R GONYO G MONGE A CUTLER DL
Citation: Rd. Huhn et al., PHARMACODYNAMICS OF SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-10 IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 62(2), 1997, pp. 171-180
DISPOSITION OF RECOMBINANT HUMAN INTERLEUKIN-10 (IL-10) IN PATIENTS WITH VARIOUS DEGREES OF RENAL-FUNCTION
Authors: LAMBRECHT LJ SWAN SK CUTLER DL AFFRIME MB RADWANSKI E BATRA V MACRES M
Citation: Lj. Lambrecht et al., DISPOSITION OF RECOMBINANT HUMAN INTERLEUKIN-10 (IL-10) IN PATIENTS WITH VARIOUS DEGREES OF RENAL-FUNCTION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 87-87
PHARMACOKINETICS OF INTRAMUSCULARLY ADMINISTERED ISEPAMICIN IN MAN
Authors: LIN CC RADWANSKI E KORDUBA C AFFRIME M CAYEN MN
Citation: Cc. Lin et al., PHARMACOKINETICS OF INTRAMUSCULARLY ADMINISTERED ISEPAMICIN IN MAN, Chemotherapy, 43(2), 1997, pp. 86-93
RECOMBINANT HUMAN INTERLEUKIN-10 (RHIL-10) - SAFETY, PHARMACODYNAMICSAND IMMUNOHEMATOLOGIC EFFECTS OF REPENTED DAILY SUBCUTANEOUS (SC) DOSES IN HEALTHY-VOLUNTEERS
Authors: HUHN RD PENNLINE K RADWANSKI E CLARKE L SABO R AFFRIME M CUTLER DL
Citation: Rd. Huhn et al., RECOMBINANT HUMAN INTERLEUKIN-10 (RHIL-10) - SAFETY, PHARMACODYNAMICSAND IMMUNOHEMATOLOGIC EFFECTS OF REPENTED DAILY SUBCUTANEOUS (SC) DOSES IN HEALTHY-VOLUNTEERS, Blood, 90(10), 1997, pp. 1232-1232
INTERLEUKIN-10 PHARMACOKINETICS IN INTACT AND NEPHRECTOMIZED MICE
Authors: CHIU PJS RADWANSKI E TETILOFF G MONGE A SWANSON SJ
Citation: Pjs. Chiu et al., INTERLEUKIN-10 PHARMACOKINETICS IN INTACT AND NEPHRECTOMIZED MICE, European cytokine network, 7(1), 1996, pp. 67-69
CLINICAL, HEMATOLOGIC, AND IMMUNOLOGICAL EFFECTS OF INTERLEUKIN-10 INHUMANS
Authors: FUCHS AC GRANOWITZ EV SHAPIRO L VANNIER E LONNEMANN G ANGEL JB KENNEDY JS RABSON AR RADWANSKI E AFFRIME MB CUTLER DL GRINT PC DINARELLO CA
Citation: Ac. Fuchs et al., CLINICAL, HEMATOLOGIC, AND IMMUNOLOGICAL EFFECTS OF INTERLEUKIN-10 INHUMANS, Journal of clinical immunology, 16(5), 1996, pp. 291-303
COMPARATIVE BIOAVAILABILITY OF CEFTIBUTEN IN CAPSULE AND SUSPENSION FORMS
Authors: LIN CC AFFRIME M RADWANSKI E LIM J COLUCCI R CAYEN MN
Citation: Cc. Lin et al., COMPARATIVE BIOAVAILABILITY OF CEFTIBUTEN IN CAPSULE AND SUSPENSION FORMS, Clinical therapeutics, 18(6), 1996, pp. 1139-1149
INFLUENCE OF FOOD ON THE ORAL BIOAVAILABILITY OF LORATADINE AND PSEUDOEPHEDRINE FROM EXTENDED-RELEASE TABLETS IN HEALTHY-VOLUNTEERS
Authors: NOMEIR AA MOJAVERIAN P KOSOGLOU T AFFRIME MB NEZAMIS J RADWANSKI E LIN CC CAYEN MN
Citation: Aa. Nomeir et al., INFLUENCE OF FOOD ON THE ORAL BIOAVAILABILITY OF LORATADINE AND PSEUDOEPHEDRINE FROM EXTENDED-RELEASE TABLETS IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 36(10), 1996, pp. 923-930
PHARMACOKINETICS AND METABOLISM OF GENACONAZOLE, A POTENT ANTIFUNGAL DRUG, IN MEN
Authors: LIN C KIM H RADWANSKI E AFFRIME M BRANNAN M CAYEN MN
Citation: C. Lin et al., PHARMACOKINETICS AND METABOLISM OF GENACONAZOLE, A POTENT ANTIFUNGAL DRUG, IN MEN, Antimicrobial agents and chemotherapy, 40(1), 1996, pp. 92-96
EFFECT OF FELBAMATE ON VALPROIC ACID DISPOSITION IN HEALTHY-VOLUNTEERS - INHIBITION OF BETA-OXIDATION
Authors: HOOPER WD FRANKLIN ME GLUE P BANFIELD CR RADWANSKI E MCLAUGHLIN DB MCINTYRE ME DICKINSON RG EADIE MJ
Citation: Wd. Hooper et al., EFFECT OF FELBAMATE ON VALPROIC ACID DISPOSITION IN HEALTHY-VOLUNTEERS - INHIBITION OF BETA-OXIDATION, Epilepsia, 37(1), 1996, pp. 91-97
EFFECT OF FOOD AND POSTPRANDIAL STATE ON THE BIOAVAILABILITY OF MICRONIZED PROGESTERONE
Authors: KOSOGLOU T MOJAVERIAN P RADWANSKI E CHRISTOPHER D CUTLER DL LIN CC AFFRIME MB
Citation: T. Kosoglou et al., EFFECT OF FOOD AND POSTPRANDIAL STATE ON THE BIOAVAILABILITY OF MICRONIZED PROGESTERONE, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 24-24
EFFECT OF AGE ON THE PHARMACOKINETICS OF ISEPAMICIN, A NEW ONCE-DAILYAMINOGLYCOSIDE
Authors: BANFIELD C JEN F COLUCCI R GLUE P RADWANSKI E AFFRIME M
Citation: C. Banfield et al., EFFECT OF AGE ON THE PHARMACOKINETICS OF ISEPAMICIN, A NEW ONCE-DAILYAMINOGLYCOSIDE, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 104-104
PHARMACOKINETICS AND IMMUNOMODULATORY PROPERTIES OF INTRAVENOUSLY ADMINISTERED RECOMBINANT HUMAN INTERLEUKIN-10 IN HEALTHY-VOLUNTEERS
Authors: HUHN RD RADWANSKI E OCONNELL SM STURGILL MG CLARKE L CODY RP AFFRIME MB CUTLER DL
Citation: Rd. Huhn et al., PHARMACOKINETICS AND IMMUNOMODULATORY PROPERTIES OF INTRAVENOUSLY ADMINISTERED RECOMBINANT HUMAN INTERLEUKIN-10 IN HEALTHY-VOLUNTEERS, Blood, 87(2), 1996, pp. 699-705
PHARMACOKINETICS OF ISEPAMICIN
Authors: BARR WH COLUCCI R RADWANSKI E ZAMPAGLIONE N CUTLER D LIN CC ELLIOTT M AFFRIME MB
Citation: Wh. Barr et al., PHARMACOKINETICS OF ISEPAMICIN, Journal of chemotherapy, 7, 1995, pp. 53-61
PHARMACOKINETICS OF ISEPAMICIN IN PEDIATRIC-PATIENTS
Authors: SCAGLIONE F VIGANO A COLUCCI R ZAMPAGLIONE N LIN CC CUTLER D GUERCIOLINI R ELLIOTT M AFFRIME M RADWANSKI E
Citation: F. Scaglione et al., PHARMACOKINETICS OF ISEPAMICIN IN PEDIATRIC-PATIENTS, Journal of chemotherapy, 7, 1995, pp. 63-69
BIOPHARMACEUTIC CHARACTERISTICS OF A NEW EXTENDED-RELEASE THEOPHYLLINE FORMULATION (UNI-DUR)
Authors: OOSTERHUIS B BRANNAN MD GROEN H PEETERS PAM HEMPENIUS J RADWANSKI E NOMEIR AA AFFRIME MB JONKMAN JHG
Citation: B. Oosterhuis et al., BIOPHARMACEUTIC CHARACTERISTICS OF A NEW EXTENDED-RELEASE THEOPHYLLINE FORMULATION (UNI-DUR), Annals of allergy, asthma, & immunology, 75(2), 1995, pp. 157-161
COMPARISON OF 4- AND 24-HOUR INTRAVENOUS-INFUSION SCHEDULES FOR GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
Authors: WONG L TAYLOR CW RADWANSKI E HERSH EM SALMON SE
Citation: L. Wong et al., COMPARISON OF 4- AND 24-HOUR INTRAVENOUS-INFUSION SCHEDULES FOR GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, Journal of immunotherapy with emphasis on tumor immunology, 18(1), 1995, pp. 57-65
PHARMACOKINETIC VARIABILITY OF AMINOGLYCOSIDES - COMMENT
Authors: COLUCCI RD GLUE P BANFIELD CR RADWANSKI E
Citation: Rd. Colucci et al., PHARMACOKINETIC VARIABILITY OF AMINOGLYCOSIDES - COMMENT, The Annals of pharmacotherapy, 29(9), 1995, pp. 939-939
PHARMACOKINETIC INTERACTION STUDIES BETWEEN FELBAMATE AND VIGABATRIN
Authors: REIDENBERG P GLUE P BANFIELD C COLUCCI R MEEHAN J REY E RADWANSKI E NOMEIR A LIM J LIN C GUILLAUME M AFFRIME MB
Citation: P. Reidenberg et al., PHARMACOKINETIC INTERACTION STUDIES BETWEEN FELBAMATE AND VIGABATRIN, British journal of clinical pharmacology, 40(2), 1995, pp. 157-160
Risultati: 1-25 | 26-39